End-stage renal disease : CMS should assess adequacy of payment when certain oral drugs are included and ensure availability of quality monitoring data : report to congressional committees.

Bibliographic Details
Corporate Author:	United States. Government Accountability Office
Format:	Government Document eBook
Language:	English
Published:	[Washington, D.C.] : U.S. Govt. Accountability Office, [2011]
Subjects:	Oral medication > Economic aspects > United States. Hemodialysis > Patients > Economic aspects. Hemodialysis > Patients > Medical care > Government policy > United States. Centers for Medicare & Medicaid Services (U.S.) > Rules and practice. Medicare > Economic aspects.
Online Access:	https://purl.fdlp.gov/GPO/gpo12609

Available Online